Echocardiographic parameters associated with in‐hospital adverse outcomes in patients with Takotsubo syndrome - Farina - 2021 - Echocardiography - Wiley Online Library
Chemical Strategies to Boost Cancer Vaccines | Chemical Reviews
Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer | Breast Cancer Research | Full Text
Untitled
Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda
Jeremy Irons | A message from Jeremy Irons, Patron of The Greater Chernobyl Cause. | By The Greater Chernobyl Cause | Facebook
The Effect of Abdominal Aortic Aneurysm Size on Endoleak, Secondary Intervention and Overall Survival Following Endovascular Aortic Aneurysm Repair - Benjamin Ferrel, Shiv Patel, Antonio Castillo, Oscar Gryn, Jan Franko, David Chew,
![Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist | Journal of ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b00392/asset/images/large/jm-2018-003925_0009.jpeg "Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist | Journal of ...")
Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist | Journal of ...
Turki Alelyani, Stevens Institute of Technology, Arup Kumar Ghosh, Jacksonville State University Larry Moralez, University of Ce
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets | Journal of Medicinal Chemistry
Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities | Oncogene
Hospital readmissions penalties now in 5th year
Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study - Ralph HB Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial - The Lancet
Bethesda Magazine: November-December 2015 by Bethesda Magazine - Issuu
ELLE Italy October 2015 - Alena Blohm by Drew Jarrett - Fashion Editorials
New Balance Baskets - ML373 (Bleu) - Baskets chez Sarenza (503281)
Prescription Glasses, Contacts & Eye Exams | Stanton Optical
Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets | Journal of Medicinal Chemistry
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology | ACS Medicinal Chemistry Letters
Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo | ACS Infectious Diseases
Untitled
Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer | Ochsner Journal
Index Catalog // Carolina Digital Repository
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis - The Lancet Microbe
Interim monitoring using the adaptively weighted log‐rank test in clinical trials for survival outcomes - Yang - 2019 - Statistics in Medicine - Wiley Online Library
